Canntab Therapeutics

Markham, Canada

Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.

$1.0M raised

Feb 2022

Post-IPO Debt

Biotechnology Health Care Manufacturing Medical Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Canntab Therapeutics

How much funding has Canntab Therapeutics raised?

Canntab Therapeutics has raised $1.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2022.

Where is Canntab Therapeutics headquartered?

Canntab Therapeutics is headquartered in Markham, Canada.

What does Canntab Therapeutics do?

Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.

What stage is Canntab Therapeutics at?

Canntab Therapeutics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2022.

MLA

"Canntab Therapeutics — Funding & Investors." VCBacked, February 1, 2022, https://www.vcbacked.co/company/canntab-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Canntab Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/canntab-therapeutics

Wikipedia (cite web)

{{cite web |title=Canntab Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/canntab-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2022.